Introduction
Parkinson's disease is one of the most common neurodegenerative diseases that results primarily from the degeneration of dopaminergic neurons in the substantia nigra pars compacta (Bernheimer et al., 1973) . Although the precise mechanisms underlying the cell death in Parkinson's disease are not clearly established, several studies suggest that an excessive or inappropriate formation of nitric oxide ( NO) (and its derivatives) may modulate cell events that are involved in the neuronal death pathways (Przedborski et al., 1996; Schulz et al., 1997; Dawson and Dawson, 1998; Zhang et al., 2006) .
The association of NO pathways with Parkinson's disease is strengthened by studies showing that induction of iNOS (inducible nitric oxide synthase) in glial cells contributes to degeneration of dopamine-containing neurons in a mice model of Parkinson's disease (Liberatore et al., 1999) . Moreover, the inhibition of nNOS (neuronal nitric oxide synthase) prevents Parkinsonism in animal models of the disease (Schulz et al., 1995; Hantraye et al., 1996; Przedborski et al., 1996; Dehmer et al., 2000; Klivenyi et al., 2000; Watanabe et al., 2004 Watanabe et al., , 2008 .
On the other hand, the observation that cell death occurred primarily in dopaminergic neurons has focused the attention on the dopamine molecule itself and on an abnormal metabolism of dopamine as a potential mediating factor. In fact, it was reported that dopamine and its metabolites are able to induce toxicity in dopaminergic cells via mechanisms that range from an oxidative stress phenomenon (Fahn and Cohen, 1992; Rabinovic et al., 2000) to specific modifications of critical proteins, such as the covalent modification of parkin (LaVoie et al., 2005) , triggering apoptotic death in various neuronal cultures (Jones et al., 2000; Lamensdorf et al., 2000a; Kristal et al., 2001; Lotharius et al., 2005; Mazzio et al., 2004) .
Although excessive NO production and dopamine or its metabolites have been independently implicated in neurodegeneration, several other studies point to links between those two pathways (Antunes et al., 2005) . For instance, glutamate potentiates simultaneously NO production and toxic effects of dopamine towards neuronal cells (Garthwaite and Boulton, 1995) . In turn, NO regulates dopamine release in the hippocampus of rats (Segieth et al., 2000; Wegener et al., 2000) , affecting also dopamine reuptake (Cook et al., 1996) . Also, NO activates tyrosine hydroxylase (the limiting-enzyme in the synthesis of dopamine) (Roskoski and Roskoski, 1987) and mitochondrial damage by NO is potentiated by dopamine in PC-12 cells (Antunes et al., 2002) . Moreover, Laranjinha and Cadenas (2002) reported the formation of reactive intermediates from the interaction of NO with 3,4-dihydroxyphenylacetic acid (DOPAC), a major metabolite of dopamine. Later, it was demonstrated that DOPAC may act synergistically with NO, leading to mitochondrial dysfunction . Therefore, mitochondrial dysfunction and oxidative/nitrosative stress appear to coordinate pathways leading to degeneration of dopaminergic neurons.
The present study entails an assessment of the toxic effects of NO and DOPAC, independently and in combination, in rat pheochromocytoma-derived PC-12 cells.
Whereas below 200 nmol/10 6 cells, DOPAC protects the cells from NO-mediated death, when combined with NO above 200 nmol DOPAC/10 6 cells, induced an enhanced cell death, involving mitochondrial dysfunction, that is mechanistically distinct from that induced by NO as it does not involve caspases activation.
Materials and methods

Chemicals and biochemicals
DOPAC was purchased from Fluka Chemie (Neu-Ulm, Switzerland). SNAP was obtained from WPI (Sarasota, FL, USA). RPMI 1640 cell culture medium was from Sigma Chemicals Co. (St. Louis, MO, USA); fetal bovine serum (FBS) and phosphate-buffered saline (PBS) pH 7.4 were purchased from Gibco-Invitrogen. General laboratory chemicals as well as poly-lysine, MTT and Hoechst 33258 were from Sigma Chemicals Co. (St. Louis, MO, USA).
DOPAC solution was prepared in ultra pure water (obtained from a Milli-Q system, Millipore Company, Bedford, MA, USA) previously saturated with argon. This solution was prepared every day and used freshly.
To measure the concentration of NO generated by the NO donor S-nitroso-N-acetylpenicillamine (SNAP) we used the ISO-NO Mark II nitric oxide meter and sensor from WPI (Sarasota, FL, USA).
Cell culture
The rat pheochromocytoma cell line PC-12, purchased from ECACC (European Collection of Cell Cultures), was routinely grown in RPMI 1640 medium without antibiotics supplemented with heat-inactivated fetal bovine serum (FBS) (10%, v/v) onto 75 cm 2 flasks and maintained at 37 8C, in a humidified atmosphere of 5% CO 2 . Cells were plated (5 Â 10 4 cells cm À2 ) 24 h before experiments. The medium was always replaced by fresh medium before treatments of the cells.
Analysis of cell viability
The cell viability was assessed by using the MTT assay, which is based on the reduction of the dye MTT to formazan, an insoluble intracellular blue product, by cellular dehydrogenases (Denizot and Lang, 1986) . Briefly, after incubation of the cells under the specified conditions, the culture medium was removed, and the cells washed twice with PBS. Then MTT was added to each well at a final concentration of 0.5 mg/ml. Following incubation during 1 h at 37 8C, MTT was removed and 1 ml of DMSO was added and mixed thoroughly until formazan crystals were dissolved. The mixture was then collected from each well and the extent of MTT reduction was measured spectrophotometrically at 540 nm. Cell viability was expressed as a percentage of the control cultures.
Evaluation of cell death
The plasma membrane integrity was assessed indirectly by measuring the activity of the cytoplasmic enzyme lactate dehydrogenase (LDH) in the extracellular medium. LDH activity was spectrofluorimetrically evaluated in an auto analyzer Synchron CX (Beckman Coulter) following the manufacturer's instructions. Results were expressed as percentage of total LDH release. Total cellular LDH was determined after lysing the cells.
Assessment of cellular morphology
The cellular morphology was analysed with the May-Grü nwald-Giemsa staining. PC-12 cells were plated onto glass coverslips coated with poly-lysine. After incubation under the specified conditions, the cells were washed twice with PBS, fixed with 4% (w/ v) paraformaldehyde in PBS (15 min), rinsed, and stained with a May-Grü nwald solution for 5 min at room temperature. Then cells were stained with Giemsa solution for 15 min at room temperature. Cells were rinsed with water. The stained cells were visualized using a Zeiss Axiovert 40 CFL microscope equipped with an Axiocam MRc camera. Only cells that remained attached to the plates were observed.
Assessment of nuclear morphology
The nuclear morphology was analysed with Hoechst 33258, a fluorescent dye that specifically labels nuclear DNA. PC-12 cells were plated onto glass coverslips coated with poly-lysine. After incubation under the specified conditions, the cells were washed twice with PBS, fixed with 4% (w/v) paraformaldehyde in PBS (15 min), rinsed, and stained with Hoechst 33258 (5 mg/ml) for 10 min at room temperature. The stained cells were visualized using a Nikon fluorescence microscope employing a DAPI filter. Only cells that remained attached to the plates were observed.
Measurement of cytochrome c release
The release of cytochrome c from mitochondria into the cytosol was assessed by western blot. Briefly, following incubation under the specified conditions, the cells were scraped and centrifuged at 500 Â g for 5 min. Then the cells were washed twice with PBS and resuspended on lysis buffer, consisting of 75 mM NaCl, 1 mM NaH 2 PO 4 , 8 mM Na 2 HPO 4 , 250 mM sucrose supplemented with 200 mg digitonin/ml and 1:100 of a broad spectrum protease inhibitor cocktail (Sigma Chemical Co.). After vigorous vortexing this suspension was centrifuged at 14 000 rpm for 3 min at 48 C and the supernant, corresponding to the cytosolic fraction, recovered.
Briefly, 25 mg of cytosolic protein extract was loaded onto each lane of a SDS-polyacrylamide gel. The separated proteins were electrotransferred to a polyvinylidene difluoride membrane (Amersham Pharmacia Biotech, Buckinghamshire, UK). The membranes were blocked for 2 h at room temperature with blocking buffer (15 mM NaCl, 2.5 mM Tris-HCl, pH 7.6, and 0.1% Tween-20) containing 5% non-fat dry milk. The blots were then incubated with primary mouse monoclonal antibody against the denatured form of cytochrome c (1:1000, Pharmingen, San Diego, Ca, USA). The membranes were then washed during 30 min and incubated with an alkaline phosphatase-conjugated antibody to mouse immunoglobulin (Ig) (1.15000, Abcam, Cambridge, UK), for 2 h at room temperature. The bands were revealed with ECF (Amersham Pharmacia Biotech, Buckinghamshire, UK) and visualised by using a Versa-Doc Imaging System, model 3000 (BioRad, Hercules, CA, USA). The images were analysed with the Quantity One software (BioRad). b-Actin was used as a loading control. Protein concentrations were quantified by the BioRad protein assay dye, using bovine serum albumin as the standard.
Measurement of caspase activity
Following the treatment with DOPAC, SNAP or DOPAC plus SNAP, the cells were harvested and washed twice in PBS. Then, cells were resuspended on a ice lysis buffer consisting of 1 mM Naethylenediaminetetraacetic acid (Na-EDTA), 1 mM Na-ethylene glycol-bis(b-aminoethylether)-N,N-tetraacetic acid (Na-EGTA), 2 mM MgCl 2 Á6H 2 O, 25 mM HEPES (pH 7.5) supplemented with 0.1% CHAPS, 100 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM DTT, and 1:100 of a broad spectrum protease inhibitor cocktail (Sigma Chemical Co.). After freezing during three times in liquid nitrogen, the cell extracts were centrifuged at 15 800 Â g for 10 min, at 4 8C and the supernatants were stored at À80 8C. To measure caspase activity, aliquots of lysates containing 25 mg of protein were added to a reaction buffer (25 mM HEPES, pH 7.5) supplemented with 0.1% CHAPS, 5 mM DTT and 100 mM PMSF. The reactions were initiated after addition of the following fluorimetric substrates (50 mM final concentration): Ac-DEVD-Amc for caspase-3-like activity, Ac-IETD-Amc for caspase-8-like activity and Ac-LEDH-Afc for caspase-9-like activity. After 150 min of incubation at 37 8C the cleavage of the substrates was measured (Amc, l excitation 390 nm and l emission 475 nm; Afc, l excitation 400 nm and l emission 505 nm). Caspases activity was expressed as a percentage of the value in control cultures.
Determination of ATP levels
PC-12 cells were seeded onto 40 mm Petri dish. Following the period of incubation, the medium was removed and the cells were rinsed twice with PBS. Then ice-cold 0.3 M perchloric acid was added and the cells were scraped, collected into Eppendorf tubes, and centrifuged at 15,800 Â g, for 5 min at 4 8C. The pellets were analysed for total protein content using the BioRad protein assay kit. The supernatants were neutralized with 10 M KOH in 5 M Tris and further centrifuged at 15,800 Â g, for 10 min at 4 8C to remove the potassium perchlorate salt. The resulting supernatants were assayed for adenosine triphosphate (ATP) using a reverse-phase HPLC methodology, as described by Stocchi et al. (1985) The chromatographic apparatus was a Beckman System Gold, consisting of a 126 binary Pump Model and a 166 Variable UV detector controlled by a computer. The column was a Lichrospher 100 RP-18 (5 mM) from Merck (Germany). An isocratic elution with 100 mM KH 2 PO 4 buffer at pH 6.5 with 1% methanol was performed at flow rate of 0.9 ml/min. The adenine nucleotides were detected at 254 nm.
Fluorimetric analysis of mitochondrial membrane potential
Changes in mitochondrial membrane potential (Dc m ) were estimated using the fluorescent cationic dye rhodamine 123 (RH 123) as described by Palmeira et al. (1996) . RH 123 accumulates electrophoretically in mitochondria as a direct function of the membrane potential and is released upon membrane depolarization. Cells were incubated at 37 8C, for 15 min, with 10 mM RH 123. Then the cells were washed three times with phosphate buffer, centrifuged, resuspended in RPMI 1640 medium without phenol red and transferred to a fluorometer cuvette. The fluorescence at excitation and emission wavelengths of 505 nm and 525 nm at 30 8C was recorded during 3 min using a PerkinElmer LS-50B spectrofluorometer. Then FCCP was added causing release of rhodamine 123 and consequently an increase in fluorescence. Results are expressed as a percentage of the dye retained within control cells.
Immunocytochemistry
Following incubation under the specified conditions, the cells were washed twice with PBS. Then, MitoTracker Deep Red (mitochondria) was added to the culture to a final concentration of 200 nM and incubated for 30 min. Afterwards, the cells were washed twice with PBS and fixed with 4% paraformaldehyde in PBS for 15 min at room temperature. After blocking and permeabilization with PBS containing 0.1% saponin and 5% FBS for 30 min at room temperature, cells were incubated with a mouse monoclonal primary antibody anti-apoptotic-inducing factor (AIF) (1:100) (Santa Cruz Biotech, Santa Cruz, USA) for 1 h at room temperature. Cells were rinsed three times with PBS and then incubated with Alexa fluor 488-conjugated secondary antibody (donkey antimouse IgG, 1:1000) (Molecular Probes, Eugene, OR, USA). The nuclei were stained with Hoechst 33258 (5 mg/ml) for 10 min at room temperature. Cells were washed, mounted with Mowiol and observed in a Zeiss Confocal microscope.
Statistical analysis
All data were expressed as mean AE S.E.M. of at least three independent assays, each one in duplicate. Significance between groups was assessed by one-way analysis of variance (ANOVA). A value of p lower than 0.05 was considered statistically significant.
Results
DOPAC modulation of NO-induced toxicity on PC-12 cells
PC-12 cells were treated with two concentrations (0.5 and 1 mM) of a NO donor, SNAP, and assayed for cytotoxicity after 1, 14 and 24 h incubation (Fig. 1) . Typically, NO release from 1 mM SNAP, in the presence of cells, reached a steady-state level between 0.8 and 1.3 mM after 1 h in RPMI 1640 medium. Moreover, it was checked that completely decomposed SNAP had no effect on the cell viability (not shown). Fig. 1 shows that SNAP reduced the viability of PC-12 cells in a time-and concentration-dependent manner. Indeed, whereas 0.5 mM SNAP induced a 19.6 AE 3.3% and a 28.3 AE 1.8% loss of cell viability, at 14 h and 24 h, respectively, 1 mM SNAP induced a 34.9 AE 1.1% and a 52.7 AE 1.7% loss of cell viability for identical time ranges (Fig. 1) . At 1 h of incubation, the cell viability was identical to the control. Fig. 2 shows that the toxicity induced by SNAP is modulated by DOPAC, being the final outcome affected by the concentration of both compounds. When the cells are challenged with 0.5 mM SNAP, DOPAC at 200-400 nmol/10 6 cells are protective but 800 nmol/10 6 cells is devoided of an effect, being similar to 0.5 mM SNAP (Fig. 2a) . When 1 mM SNAP is used the cells are protected by 200 nmol DOPAC/10 6 cells, but for higher DOPAC/cell ratios an increase in toxicity is obvious (Fig. 2b) . Further considering that DOPAC alone, at the concentrations used, had no significant effect on the cell viability for the incubation times shown (data not shown), the results suggest that the cells are sensitive to DOPAC/ NO concentration ratio, the lower the concentration of NO, the higher the concentration of DOPAC needed to stimulate toxicity.
Mechanisms of toxicity 3.2.1. LDH leakage
The integrity of plasma membrane was evaluated as a feature typical of necrosis, by measuring LDH leakage to the extracellular medium induced by 800 nmol DOPAC/10 6 cells, 1 mM SNAP and 800 nmol DOPAC/10 6 cells in combination with 1 mM SNAP after 1 h, 4 h, 6 h, 8 h and 24 h of incubation. During the first 8 h of incubation the membrane integrity of PC-12 cells incubated with SNAP or DOPAC plus SNAP were not significantly affected demonstrating that the cells were still viable (Fig. 3) . It is of note that membrane integrity is maintained while loss of mitochondrial potential and ATP loss is observed (Figs. 5 and 6 below). However, as shown in Fig. 3 , after 24 h of incubation with DOPAC plus SNAP, a higher and significant increase of extracellular LDH activity was observed (72.8 AE 3.4), as compared with the cells incubated with SNAP only (30 AE 3.5). It is important to note that DOPAC did not induce a significant LDH release into the extracellular medium during 24 h (Fig. 3) .
Cellular and nuclear morphology
Hallmarks of classic apoptosis include specific morphological changes, such as cell shrinkage, blebbing, chromatin condensation, nuclear fragmentation and loss of adhesion (Kerr et al., 1972) . So, in order to investigate the process of cell death induced by SNAP and DOPAC plus SNAP, the cellular and nuclear morphology of cells treated under the different experimental conditions were analysed by using the May-Grü nwald-Giemsa dye and the fluorescent nuclear dye Hoechst 33258, respectively (Fig. 4) . Control cells showed a round or spherical morphology with regular and roundshaped nuclei (Fig. 4) , whereas treated PC-12 cells manifested a different morphology depending on the experimental conditions. In cultures exposed to 1 mM SNAP, cells were round but some of them showed the nuclei reduced in size and with an irregular shape (Fig. 4) . Few blebbing cells are also apparent (Fig. 4) . DOPAC plus SNAP-treated cells had a reduced volume when compared . After 24 h, the tissue culture media was replaced by fresh media and the cells were incubated with 0.5 mM SNAP or 1 mM SNAP as indicated in the figure. Cell viability was measured at indicated times by determining the cellular reducing capacity, by following the extent of MTT reduction, as described in Section 2. Data represent the mean AE S.E.M. of at least six independent experiments in triplicate and are expressed as percentage of control cells. with control cells (cell shrinkage) and the nucleus was strongly condensed (Fig. 4) , suggestive of an apoptotic-type mechanism and not a necrotic cell death. Under both conditions, no fragmentation was observed. Note that cells treated with 800 nmol DOPAC/10 6 cells ( Fig. 4) did not exhibit noticeable modifications of nuclear morphology relatively to the control cells (Fig. 4) .
Mitochondrial membrane potential and ATP
Mitochondrial function is very sensitive to the presence of nitric oxide (Brown, 1995; Borutaite and Brown, 1996; Lizasoain et al., 1996; Giulivi, 1998; Brookes et al., 1999; Brown, 1999) and the mechanism by which NO induces apoptosis in several cell types appears to encompass changes in mitochondrial membrane potential (Dc m ) (Almeida et al., 2001; Bal-Price and Brown, 2000; Brorson et al., 1999; Solenski et al., 2003) . To investigate the alteration of Dc m in PC-12 cells treated with DOPAC, SNAP or DOPAC plus SNAP, the fluorescent probe RH 123 was used as described in Section 2. As shown in Fig. 5 , after 1 h of incubation, both, SNAP and DOPAC plus SNAP, induced a significant loss of Dc m (72.95 AE 1.2 and 60.75 AE 2.14, respectively). The dissipation of Dc m increased with time under both situations. However, the loss of Dc m was significantly stronger in the cells incubated with DOPAC plus SNAP (Fig. 5) . DOPAC had no effect on the Dc m (data not shown). Fig. 6 shows that incubation of cells with 1 mM SNAP or with 800 nmol DOPAC/10 6 cells plus 1 mM SNAP during 1 h resulted in a similar and significant fall in ATP concentration as compared with the control. However, whereas in the case of cells incubated with 1 mM SNAP, the initial fall in ATP concentration remained unchanged along the incubation time, in the cells co-incubated with DOPAC plus SNAP, ATP concentrations fell progressively over the incubation period. We also evaluated lactate release to the culture medium as an index of glycolytic activity (data not shown).
In the cells incubated during 8 h with SNAP, but not in the cells coincubated with DOPAC plus SNAP, an increase in the lactate production occurred (data not shown). Therefore, these results indicate that DOPAC potentiates the NO-induced ATP depletion in PC-12 cells. In cells incubated with DOPAC alone, we did not observe any significant alteration of the ATP content (Fig. 6 ).
Cytochrome c release
A fall in the Dc m , may culminate in the release of several proapototic factors from the mitochondrial intermembrane space (1 mM) or with the combination of both. After 14 h cells were fixed and stained as described in Section 2. Cell morphology was examined with a Contrast of Phase microscope (left panel) and the nuclear morphology was examined with a fluorescence microscope (right panel).
to cytosol, notably cytochrome c (Ly et al., 2003) . Consequently, we investigated whether cytochrome c release occurred in the cells incubated with SNAP or DOPAC plus SNAP. A western blot analysis of cytosolic fractions derived from PC-12 cells showed that the cytosolic content of cytochrome c increased significantly after 8 h of incubation with SNAP and DOPAC plus SNAP (Fig. 7) , indicating a release of cytochrome c from mitochondria. However, the concentration of cytochrome c in cytosol was higher in cells incubated with DOPAC plus SNAP (577 AE 40%) as compared with SNAP alone (277 AE 67%). DOPAC itself did not induce a significant release of cytochrome c when compared with control cells (Fig. 7) .
Caspase activation
The release of cytochrome c from mitochondria can initiate activation of apoptotic proteases, caspases, leading to cell death. To examine whether the cell death induced by SNAP or DOPAC plus SNAP is related to a pathway involving the activation of caspases, we studied the time course of the activation of caspase-3-, 8-and 9-like proteases. Cytosolic fractions from PC-12 cells were exposed to DOPAC, SNAP or DOPAC plus SNAP for different times (30 min, 2 h, 4 h, 6 h, 8 h, and 14 h) and tested for the cleaving activity of three fluorogenic substrates (Ac-DEVD-Amc, Ac-IETD-Amc or Ac-LEDH-Afc) as described under Section 2. As shown in Fig. 8a , following 14 h treatment of PC-12 cells with 1 mM SNAP, we detected a 1.5-fold increase of caspase-9-like activity as compared with the control. Conversely, in PC-12 cells incubated with DOPAC plus SNAP this caspase was partially inactivated (Fig. 8a) . Similarly, caspase-3 showed a significant activation in cells treated 14 h with 1 mM SNAP (1.6-fold the control value) (Fig. 8b ) but no activation of caspase-3-like activity was detected up to 14 h after treatment with DOPAC plus SNAP (Fig. 8b) .
Under both conditions of incubation, SNAP or DOPAC plus SNAP, caspase-8-like activity was not significantly altered as compared with the activity of untreated cells (data not shown). In cells incubated with DOPAC, the basal activity of these three caspases was similar to basal activity of control cells (data not shown).
To confirm these results, we assessed, with the MTT assay, the cell viability after 24 h treatment with SNAP or DOPAC plus SNAP in the presence of the z-VAD-fmk, which is widely used as a cellpermeant caspase inhibitor in different experimental models, including PC-12 cells (Fujita et al., 2006) . 30 mM z-VAD-fmk partially protected the cells incubated with 1 mM SNAP but had no protective effect in the cell viability observed in the cells coincubated with DOPAC plus SNAP (data not shown).
Thus, the results suggest that, conversely to SNAP, DOPAC plus SNAP does not induce a typical caspase-dependent process apoptosis, but some alternative type of programmed cell death that is caspase independent. Therefore, DOPAC, not only potentiated NO-induced cell death, but also modifies the type of programmed cell death induced by NO. 
AIF nuclear translocation
Because apoptotic-inducing factor is known to be involved in the induction of apoptotic cell death via a caspase-independent pathway, we next examined whether AIF plays a role in the mechanisms underlying cell death induced by DOPAC plus SNAP Susin et al., 1999; Loeffler et al., 2001) . Cells were incubated with DOPAC (800 nmol/10 6 cells), 1 mM SNAP or DOPAC plus SNAP during 8 h, 14 h and 24 h and then submitted to immunostaining, as indicated in Section 2, with an AIF antibody, concurrently with the mitochondrial marker MitoTracker Deep Red and Hoechst, a nuclear dye. Fig. 9 shows the results obtained after 8 h of incubation and, apparently, the translocation of AIF to the nucleus did not occur, suggesting that AIF is not mechanistically involved in the cell death induced by DOPAC plus SNAP.
Discussion
It has been shown that under conditions of excessive or inappropriate formation NO and its derivatives may cause neuronal cell death via mechanisms involving, among others, mitochondrial dysfunction (Dawson and Dawson, 1998; Bolañ os et al., 1997; Brown, 1999) .
We have previously shown that DOPAC, a major metabolic product of dopamine, inhibits mitochondrial respiration synergistically with NO in isolated brain mitochondria . Considering that this event could contribute to the mechanisms of cell death observed during Parkinson's disease, in the present study, we demonstrated that DOPAC modulates the toxic effects of NO in undifferentiated rat pheochromocytoma-derived PC-12 cells, a cell line widely used as a model for dopaminergic neurons and known to synthesize, store, release and metabolize dopamine in a manner analogous to that of cells in vivo in the mammalian central nervous system (Greene and Tischler, 1976) . The undifferentiated PC-12 cells, while preserving dopamine metabolism, are more sensitive to oxidative stress as compared with differentiated cells (Ekshyyan and Aw, 2005) .
Once ascertained the concentration of NO that caused a significant decrease in cell viability (Fig. 1) , we showed that DOPAC affects cell survival in a way dependent on the concentration of both, DOPAC and NO (Fig. 2) . For 0.5 mM SNAP (corresponding to a steady-state concentration of about 0.5 mM NO), DOPAC prevented NO-dependent toxicity when present up to 800 nmol/10 6 cells in the medium (Fig. 2a) . If the concentration of SNAP doubles (corresponding to a steady-state concentration of about 1 mM NO), 400-800 nmol DOPAC/10 6 cells acted synergistically with NO to cause cell death (Fig. 2b) .
That NO, depending on several conditions (e.g., flux of NO and time of exposure) and factors (e.g. concentration of oxygen, superoxide radical and thiols), may induce cell death via programmed mechanisms or by necrosis, is extensively documented (Borutaite and Brown, 2005) in several cell types (Bal-Price and Brown, 2000; Terwel et al., 2000; Yuyama et al., 2003) . These reports differ not only in the cell type studied but also in the steady-state concentration of the NO, redox species involved and the chemistry it undergoes in a given biological milieu. Under our experimental conditions, both NO and the combined action of DOPAC and NO induced a programmed cell death; only after 24 h of incubation necrosis is significantly increased (Fig. 3) . Moreover, the results indicate that mitochondrial dysfunction is mechanistically involved in the death pathways induced by both, NO and DOPAC plus NO because an early loss (1 h) of Dc m and a depletion of ATP (Figs. 5 and 6, respectively) were observed when signs of cell death were not apparent yet (Figs. 1-3) . Preliminary results also indicate that respiratory chain complexes were affected (data not shown). Clearly, Figs. 5 and 6 show that DOPAC had no effect in the Dc m and in the ATP levels, but it was able to potentiate the NOinduced Dc m decrease and ATP loss, thus acting synergistically with NO in the potential induction of mitochondrial dysfunction. These findings are in agreement with our previous work showing a synergistic inhibition of respiration in isolated rat brain mitochondria by NO and DOPAC . In fact, mitochondria is likely the preferential subcellular setting for the interaction of DOPAC with NO, a statement that may be understood in connection with several lines of evidence, namely: (a) DOPAC synthesis occurs in the mitochondrial matrix via the activity of an unspecific aldehyde dehydrogenase (Ambroziak and Pietruszko, 1991; Keung and Vallee, 1998; Tank et al., 1981) ; (b) the steady-state level of NO in the mitochondrial matrix is expected to be particularly high (Boveris et al., 2000) partially due to the activity of the mitochondrial nitric oxide synthase (mtNOS) (Ghafourifar and Richter, 1997; Giulivi et al., 1998) and also due to the diffusion of NO from other cellular compartments and c) mitochondrial dysfunction seems to have a major role in the pathogenesis of Parkinson's disease (Mizuno et al., 1998; Schapira et al., 1992) .
Although, mitochondria is likely to play a center stage in the mechanisms of NO and DOPAC plus NO toxicities, it appears that DOPAC diverts cell death via a distinct programmed pathway. This notion is supported by the observation that whereas, NO seems to induce a classical apoptotic programmed cell death with release of cytochrome c from mitochondria (Fig. 7) , chromatin condensation (Fig. 4) and activation of caspase-9 (Fig. 8a ) and caspase-3 (Fig. 8b) , when the cells were incubated with DOPAC plus SNAP, cytochrome c release (but in much higher extension than for SNAP alone) ( Fig. 7) and condensation of nucleus (Fig. 4 ) occurred in the absence of caspases activation ( Fig. 8a and b) . In fact, several studies suggest that in this neurodegenerative disease the neurons can die by a caspase-independent cell death (Graeber et al., 1999; Han et al., 2003; Chu et al., 2005; Liou et al., 2005) . In order to investigate the mechanisms underlying cell death induced by DOPAC plus SNAP, we checked whether the apoptoticinducing factor (AIF), identified as a key player in the caspaseindependent cell death pathway Susin et al., 1999; Loeffler et al., 2001 ) could be involved. AIF is a flavoprotein that in normal conditions is confined to the mitochondrial intermembrane space. In response to apoptogenic stimulus, AIF translocates to the nucleus where it induces chromatin condensation and high molecular weight DNA fragmentation, as well as it evokes dissipation of the Dc m and exposure of phosphatidylserine (Susin et al., 2000) . However, immunofluorescence experiments suggest that AIF did not translocate to the nucleus (Fig. 9) . So, AIF is not the molecule responsible for the cell death that occurs in cells co-incubated with DOPAC and NO. Lysis of the cells occurred in a late stage of cell death and constitutes probably a secondary necrosis (Fig. 3) . Preliminary results -not shown -also indicate that calpains are not involved in the mechanisms of cell death.
Therefore, one may conclude that not only DOPAC potentiates NO-induced cell death but also modifies the mechanisms of cell death induced by NO. Considering that NO and DOPAC may interact yielding free radicals and other reactive species (REF), an oxidative/nitrosative stress is likely to occur. Given the experimental design used, in which the cells were challenged with a NO donor and DOPAC, it is important to ascertain that the effects observed are not irrelevant positive results due to an artificial acute damage mediated by oxidation products of DOPAC and NO chemically produced in the cell incubation medium. First, when cells are loaded with dopamine, in order to increase intracellular DOPAC content, and subsequently exposed to NO, the effects of DOPAC plus NO are mimicked in terms of increased cell death (not shown). Likewise, glipizide (100 mM), an inhibitor of DOPAC transport, in the presence of NO donor, also potentiated cell death (not shown). These experimental designs were however less reproducible as compared with the situation when cells were directly challenged with DOPAC. Second, even when the cells were incubated during only 1 h with the DOPAC/SNAP and the medium replaced afterwards, cell death still occurred for later times (not shown). Third, the occurrence of mitochondrial potential loss (Fig. 5 ) and ATP decline (Fig. 6) under conditions of maintenance of membrane integrity (Fig. 3) imparts biological significance to the experimental model. In connection with this notion, it is also of note to consider that 50-200 mM DOPAC are required to achieve a higher DOPAC intracellular steady concentration as PC-12 cells actively secret acidic dopamine metabolites into the surrounding extracellular medium (Lamensdorf et al., 2000b, c) . Under our experimental conditions, following 15 min of incubation, a six-fold increase in intracellular DOPAC was observed when cells were incubated with NO plus 800 nmol DOPAC/10 6 cells (not shown).
In regards to concerns of the physiological significance of high DOPAC concentrations, one might envisage the following situation: since Parkinson's disease is a neurodegenerative disease associated with aging and chronic oxidative stress is involved in the aging process, old dopaminergic neurons could become more susceptible to cell death induced by NO in presence of lower concentrations of DOPAC.
The synergistic interaction between DOPAC and NO shown here in promoting cell death may also acquire significance for Parkinson's disease under conditions of an increased production of both, NO and DOPAC, in dopaminergic neurons. In this regard, one may consider the following notions: (i) the concentration of DOPAC found in rat cerebrospinal fluid (CSF) obtained from the third ventricle was c.a. 1.2 mM (Mignot et al., 1984) . If one assumes that a concentration gradient is operative from its local of synthesis (the mitochondria) and the extracellular fluid, its concentration in brain mitochondria might be much higher than that in CSF; (ii) an increased turnover of dopamine (synthesis and metabolism) is observed in the early stages of Parkinson's disease (Bernheimer et al., 1973; Hornykiewicz and Kish, 1996; Strange, 1992) . Such a compensatory mechanism, increasing the cytoplasmic availability of dopamine, may boost DOPAC concentration due to activated monoamine oxidase activity (Hastings and Zigmond, 1997; Cubells et al., 1994; Sulzer et al., 1995) ; (iii) an increased NO formation in Parkinson's disease has been widely suggested (Gerlach et al., 1999; Hantraye et al., 1996; Itzhak and Ali, 1996; Schulz et al., 1997) .
Therefore, the cell death accompanied by mitochondrial dysfunction and caspase-independent pathways potentiated by DOPAC in the presence of NO may be of significance in the mechanisms of cellular degeneration underlying Parkinson's disease.
